Processa Pharmaceuticals Ownership 2024 | Who Owns Processa Pharmaceuticals Now?

Overview ForecastFinancials Chart

Institutional Ownership

4.19%

Insider Ownership

10.68%

Retail Ownership

85.13%

Institutional Holders

18.00

Processa Pharmaceuticals Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WELLS FARGO & COMPANY/MN	-	-	-	-3,247	-100.00%	-	Mar 31, 2024
NORTHERN TRUST CORP	-	-	-	-28,139	-100.00%	-	Mar 31, 2024
STATE STREET CORP	-	-	-	-42,786	-100.00%	-	Mar 31, 2024
VANGUARD GROUP INC	-	-	-	-234,653	-100.00%	-	Mar 31, 2024
ROYAL BANK OF CANADA	-	-	-	-46,306	-100.00%	-	Mar 31, 2024
COURIER CAPITAL LLC	-	-	-	-12,000	-100.00%	-	Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-58,200	-100.00%	-	Mar 31, 2024
TWO SIGMA INVESTMENTS, LP	-	-	-	-18,677	-100.00%	-	Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-122,033	-100.00%	-	Mar 31, 2024
BLACKROCK INC.	-	-	-	-293	-100.00%	-	Mar 31, 2024
CITADEL ADVISORS LLC	-	-	-	-315,410	-100.00%	-	Mar 31, 2024
HRT FINANCIAL LP	-	-	-	-11,717	-100.00%	-	Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-1,195	-100.00%	-	Mar 31, 2024
ALLWORTH FINANCIAL LP	-	-	-	-1,700	-100.00%	-	Mar 31, 2024
UBS GROUP AG	-	-	-	-80,023	-100.00%	-	Mar 31, 2024
COASTAL BRIDGE ADVISORS, LLC	-	-	-	-64,956	-100.00%	-	Mar 31, 2024
MCCOLLUM CHRISTOFERSON GROUP LLC	-	-	-	-12,500	-100.00%	-	Mar 31, 2024

Processa Pharmaceuticals's largest institutional shareholder is WELLS FARGO & COMPANY/MN, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WELLS FARGO & COMPANY/MN	-	-	-	-3,247	-100.00%	-	Mar 31, 2024
NORTHERN TRUST CORP	-	-	-	-28,139	-100.00%	-	Mar 31, 2024
STATE STREET CORP	-	-	-	-42,786	-100.00%	-	Mar 31, 2024
VANGUARD GROUP INC	-	-	-	-234,653	-100.00%	-	Mar 31, 2024
ROYAL BANK OF CANADA	-	-	-	-46,306	-100.00%	-	Mar 31, 2024
COURIER CAPITAL LLC	-	-	-	-12,000	-100.00%	-	Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-58,200	-100.00%	-	Mar 31, 2024
TWO SIGMA INVESTMENTS, LP	-	-	-	-18,677	-100.00%	-	Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-122,033	-100.00%	-	Mar 31, 2024
BLACKROCK INC.	-	-	-	-293	-100.00%	-	Mar 31, 2024
CITADEL ADVISORS LLC	-	-	-	-315,410	-100.00%	-	Mar 31, 2024
HRT FINANCIAL LP	-	-	-	-11,717	-100.00%	-	Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-1,195	-100.00%	-	Mar 31, 2024
ALLWORTH FINANCIAL LP	-	-	-	-1,700	-100.00%	-	Mar 31, 2024
UBS GROUP AG	-	-	-	-80,023	-100.00%	-	Mar 31, 2024
COASTAL BRIDGE ADVISORS, LLC	-	-	-	-64,956	-100.00%	-	Mar 31, 2024
MCCOLLUM CHRISTOFERSON GROUP LLC	-	-	-	-12,500	-100.00%	-	Mar 31, 2024

The largest Processa Pharmaceuticals shareholder by % of total assets is WELLS FARGO & COMPANY/MN. The company owns 0.00 shares of Processa Pharmaceuticals (PCSA), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BLACKROCK INC.	-	-	-	-293	-100.00%	-	Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-1,195	-100.00%	-	Mar 31, 2024
ALLWORTH FINANCIAL LP	-	-	-	-1,700	-100.00%	-	Mar 31, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-3,247	-100.00%	-	Mar 31, 2024
HRT FINANCIAL LP	-	-	-	-11,717	-100.00%	-	Mar 31, 2024
COURIER CAPITAL LLC	-	-	-	-12,000	-100.00%	-	Mar 31, 2024
MCCOLLUM CHRISTOFERSON GROUP LLC	-	-	-	-12,500	-100.00%	-	Mar 31, 2024
TWO SIGMA INVESTMENTS, LP	-	-	-	-18,677	-100.00%	-	Mar 31, 2024
NORTHERN TRUST CORP	-	-	-	-28,139	-100.00%	-	Mar 31, 2024
STATE STREET CORP	-	-	-	-42,786	-100.00%	-	Mar 31, 2024
ROYAL BANK OF CANADA	-	-	-	-46,306	-100.00%	-	Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-58,200	-100.00%	-	Mar 31, 2024
COASTAL BRIDGE ADVISORS, LLC	-	-	-	-64,956	-100.00%	-	Mar 31, 2024
UBS GROUP AG	-	-	-	-80,023	-100.00%	-	Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-122,033	-100.00%	-	Mar 31, 2024
VANGUARD GROUP INC	-	-	-	-234,653	-100.00%	-	Mar 31, 2024
CITADEL ADVISORS LLC	-	-	-	-315,410	-100.00%	-	Mar 31, 2024

As of Mar 31 2024, Processa Pharmaceuticals's largest institutional buyer is BLACKROCK INC.. The company purchased -0.29K stocks of PCSA, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CITADEL ADVISORS LLC	-	-	-	-315,410	-100.00%	-	Mar 31, 2024
VANGUARD GROUP INC	-	-	-	-234,653	-100.00%	-	Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-122,033	-100.00%	-	Mar 31, 2024
UBS GROUP AG	-	-	-	-80,023	-100.00%	-	Mar 31, 2024
COASTAL BRIDGE ADVISORS, LLC	-	-	-	-64,956	-100.00%	-	Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-58,200	-100.00%	-	Mar 31, 2024
ROYAL BANK OF CANADA	-	-	-	-46,306	-100.00%	-	Mar 31, 2024
STATE STREET CORP	-	-	-	-42,786	-100.00%	-	Mar 31, 2024
NORTHERN TRUST CORP	-	-	-	-28,139	-100.00%	-	Mar 31, 2024
TWO SIGMA INVESTMENTS, LP	-	-	-	-18,677	-100.00%	-	Mar 31, 2024
MCCOLLUM CHRISTOFERSON GROUP LLC	-	-	-	-12,500	-100.00%	-	Mar 31, 2024
COURIER CAPITAL LLC	-	-	-	-12,000	-100.00%	-	Mar 31, 2024
HRT FINANCIAL LP	-	-	-	-11,717	-100.00%	-	Mar 31, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-3,247	-100.00%	-	Mar 31, 2024
ALLWORTH FINANCIAL LP	-	-	-	-1,700	-100.00%	-	Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-1,195	-100.00%	-	Mar 31, 2024
BLACKROCK INC.	-	-	-	-293	-100.00%	-	Mar 31, 2024

As of Mar 31 2024, Processa Pharmaceuticals's biggest institutional seller is CITADEL ADVISORS LLC. The company sold -0.32M shares of PCSA, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CITADEL ADVISORS LLC	-	-	-	-315,410	-100.00%	-	Mar 31, 2024
VANGUARD GROUP INC	-	-	-	-234,653	-100.00%	-	Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-122,033	-100.00%	-	Mar 31, 2024
UBS GROUP AG	-	-	-	-80,023	-100.00%	-	Mar 31, 2024
COASTAL BRIDGE ADVISORS, LLC	-	-	-	-64,956	-100.00%	-	Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-58,200	-100.00%	-	Mar 31, 2024
ROYAL BANK OF CANADA	-	-	-	-46,306	-100.00%	-	Mar 31, 2024
STATE STREET CORP	-	-	-	-42,786	-100.00%	-	Mar 31, 2024
NORTHERN TRUST CORP	-	-	-	-28,139	-100.00%	-	Mar 31, 2024
TWO SIGMA INVESTMENTS, LP	-	-	-	-18,677	-100.00%	-	Mar 31, 2024
MCCOLLUM CHRISTOFERSON GROUP LLC	-	-	-	-12,500	-100.00%	-	Mar 31, 2024
COURIER CAPITAL LLC	-	-	-	-12,000	-100.00%	-	Mar 31, 2024
HRT FINANCIAL LP	-	-	-	-11,717	-100.00%	-	Mar 31, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-3,247	-100.00%	-	Mar 31, 2024
ALLWORTH FINANCIAL LP	-	-	-	-1,700	-100.00%	-	Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-1,195	-100.00%	-	Mar 31, 2024
BLACKROCK INC.	-	-	-	-293	-100.00%	-	Mar 31, 2024

Processa Pharmaceuticals's largest sold out institutional shareholder by shares sold is CITADEL ADVISORS LLC, sold -0.32M shares, valued at -, as of undefined.

Processa Pharmaceuticals Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD INDEX FUNDS	0.00%	469,306	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	118,169	-	-	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	13,028	-	-	Mar 31, 2024
Dimensional ETF Trust	0.00%	5,764	-	-	Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	6,502	-	-	Jan 31, 2024
EQ ADVISORS TRUST	0.00%	2,103	-	-	Mar 31, 2024
iSHARES TRUST	0.00%	27,006	-	-	Mar 31, 2024

Processa Pharmaceuticals's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 469.31K shares, compromising 0.00% of its total assets.

Processa Pharmaceuticals Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Dec, 23	18	-10.00%
30 Sep, 23	20	11.11%
30 Jun, 23	18	-18.18%
31 Mar, 23	22	22.22%
31 Dec, 22	18	-
30 Sep, 22	18	-
30 Jun, 22	18	12.50%
31 Mar, 22	16	-5.88%
31 Dec, 21	17	-5.56%
30 Sep, 21	18	12.50%
30 Jun, 21	16	14.29%
31 Mar, 21	14	75.00%
31 Dec, 20	8	-

As of 31 Dec 23, 18 institutions are holding Processa Pharmaceuticals's shares, representing a decrease of -10.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Dec, 23	1,130,700	-18.42%
30 Sep, 23	1,386,038	-0.25%
30 Jun, 23	1,389,520	-15.80%
31 Mar, 23	1,650,245	42.14%
31 Dec, 22	1,160,988	1.51%
30 Sep, 22	1,143,740	0.97%
30 Jun, 22	1,132,701	5.79%
31 Mar, 22	1,070,679	-18.91%
31 Dec, 21	1,320,364	-7.42%
30 Sep, 21	1,426,159	4.10%
30 Jun, 21	1,369,926	20.06%
31 Mar, 21	1,141,050	48.50%
31 Dec, 20	768,405	-

Processa Pharmaceuticals (PCSA) has 1.13M shares outstanding as of 31 Dec 23, down -18.42% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Dec, 23	4.19%	15.81%
30 Sep, 23	5.15%	13.82%
30 Jun, 23	6.10%	11.62%
31 Mar, 23	7.25%	12.62%
31 Dec, 22	7.58%	15.20%
30 Sep, 22	7.06%	13.98%
30 Jun, 22	7.11%	15.54%
31 Mar, 22	6.76%	9.36%
31 Dec, 21	8.50%	10.08%
30 Sep, 21	9.18%	11.61%
30 Jun, 21	8.89%	14.53%
31 Mar, 21	7.82%	7.45%
31 Dec, 20	10.25%	-

As of 31 Dec 23, Processa Pharmaceuticals is held by 4.19% institutional shareholders, representing a 15.81% growth compared to 30 Sep 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Dec, 23	10	-9.09%
30 Sep, 23	11	120.00%
30 Jun, 23	5	-58.33%
31 Mar, 23	12	33.33%
31 Dec, 22	9	50.00%
30 Sep, 22	6	-14.29%
30 Jun, 22	7	133.33%
31 Mar, 22	3	-25.00%
31 Dec, 21	4	-55.56%
30 Sep, 21	9	28.57%
30 Jun, 21	7	-22.22%
31 Mar, 21	9	12.50%
31 Dec, 20	8	-

10 institutional shareholders have increased their position in PCSA stock as of 31 Dec 23 compared to 11 in the previous quarter (a -9.09% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Dec, 23	5	25.00%
30 Sep, 23	4	-42.86%
30 Jun, 23	7	133.33%
31 Mar, 23	3	200.00%
31 Dec, 22	1	-
30 Sep, 22	1	-50.00%
30 Jun, 22	2	-33.33%
31 Mar, 22	3	-50.00%
31 Dec, 21	6	200.00%
30 Sep, 21	2	-50.00%
30 Jun, 21	4	-20.00%
31 Mar, 21	5	-
31 Dec, 20	-	-

5 institutional shareholders have reduced their position in PCSA stock as of 31 Dec 23 compared to 4 in the previous quarter (a 25.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Dec, 23	18	-10.00%	1,130,700	-18.42%	4.19%	15.81%	10	-9.09%	5	25.00%
30 Sep, 23	20	11.11%	1,386,038	-0.25%	5.15%	13.82%	11	120.00%	4	-42.86%
30 Jun, 23	18	-18.18%	1,389,520	-15.80%	6.10%	11.62%	5	-58.33%	7	133.33%
31 Mar, 23	22	22.22%	1,650,245	42.14%	7.25%	12.62%	12	33.33%	3	200.00%
31 Dec, 22	18	-	1,160,988	1.51%	7.58%	15.20%	9	50.00%	1	-
30 Sep, 22	18	-	1,143,740	0.97%	7.06%	13.98%	6	-14.29%	1	-50.00%
30 Jun, 22	18	12.50%	1,132,701	5.79%	7.11%	15.54%	7	133.33%	2	-33.33%
31 Mar, 22	16	-5.88%	1,070,679	-18.91%	6.76%	9.36%	3	-25.00%	3	-50.00%
31 Dec, 21	17	-5.56%	1,320,364	-7.42%	8.50%	10.08%	4	-55.56%	6	200.00%
30 Sep, 21	18	12.50%	1,426,159	4.10%	9.18%	11.61%	9	28.57%	2	-50.00%
30 Jun, 21	16	14.29%	1,369,926	20.06%	8.89%	14.53%	7	-22.22%	4	-20.00%
31 Mar, 21	14	75.00%	1,141,050	48.50%	7.82%	7.45%	9	12.50%	5	-
31 Dec, 20	8	-	768,405	-	10.25%	-	8	-	-	-

Processa Pharmaceuticals Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 02, 2024	Bigora Sian	officer	Chief Development Officer	F-InKind	Sell	225	$1.71	$384.75	21,878
Aug 02, 2024	Bigora Sian	officer	Chief Development Officer	F-InKind	Sell	368	$2.79	$1.03K	21,459
Aug 02, 2024	Stanker James H	officer	Chief Financial Officer	F-InKind	Sell	282	$1.71	$482.22	6,482
Aug 02, 2024	Stanker James H	officer	Chief Financial Officer	F-InKind	Sell	518	$2.79	$1.45K	6,120
Aug 02, 2024	Lin Patrick	officer	Chief Business - Strategy Off	F-InKind	Sell	271	$1.71	$463.41	29,059
Aug 02, 2024	Lin Patrick	officer	Chief Business - Strategy Off	F-InKind	Sell	539	$2.79	$1.50K	28,686

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 02, 2024	Bigora Sian	officer	Chief Development Officer	A-Award	Buy	404	-	-	27,961
Aug 02, 2024	Bigora Sian	officer	Chief Development Officer	A-Award	Buy	404	-	-	27,557
Aug 02, 2024	Bigora Sian	officer	Chief Development Officer	A-Award	Buy	2,425	-	-	27,153
Aug 02, 2024	Bigora Sian	officer	Chief Development Officer	A-Award	Buy	3,233	-	-	24,728
Aug 02, 2024	Bigora Sian	officer	Chief Development Officer	M-Exempt	Buy	644	-	-	22,103
Aug 02, 2024	Bigora Sian	officer	Chief Development Officer	F-InKind	Sell	225	$1.71	$384.75	21,878
Aug 02, 2024	Bigora Sian	officer	Chief Development Officer	M-Exempt	Buy	1,675	-	-	21,827
Aug 02, 2024	Bigora Sian	officer	Chief Development Officer	F-InKind	Sell	368	$2.79	$1.03K	21,459
Aug 02, 2024	Stanker James H	officer	Chief Financial Officer	A-Award	Buy	385	-	-	29,547
Aug 02, 2024	Stanker James H	officer	Chief Financial Officer	A-Award	Buy	385	-	-	29,162
Aug 02, 2024	Stanker James H	officer	Chief Financial Officer	A-Award	Buy	2,307	-	-	28,777
Aug 02, 2024	Stanker James H	officer	Chief Financial Officer	A-Award	Buy	3,077	-	-	26,470
Aug 02, 2024	Stanker James H	officer	Chief Financial Officer	M-Exempt	Buy	644	-	-	6,764
Aug 02, 2024	Stanker James H	officer	Chief Financial Officer	M-Exempt	Buy	1,675	-	-	6,638
Aug 02, 2024	Stanker James H	officer	Chief Financial Officer	F-InKind	Sell	282	$1.71	$482.22	6,482
Aug 02, 2024	Stanker James H	officer	Chief Financial Officer	F-InKind	Sell	518	$2.79	$1.45K	6,120
Aug 02, 2024	Lin Patrick	officer	Chief Business - Strategy Off	M-Exempt	Buy	644	-	-	29,330
Aug 02, 2024	Lin Patrick	officer	Chief Business - Strategy Off	M-Exempt	Buy	1,675	-	-	29,225
Aug 02, 2024	Lin Patrick	officer	Chief Business - Strategy Off	F-InKind	Sell	271	$1.71	$463.41	29,059
Aug 02, 2024	Lin Patrick	officer	Chief Business - Strategy Off	F-InKind	Sell	539	$2.79	$1.50K	28,686

The last insider sell of Processa Pharmaceuticals's stock was made by Bigora Sian on Aug 02 2024, selling 225 shares at $1.71 per share (valued at $384.75).

Processa Pharmaceuticals Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	1	-	-
Q1 2024	11	10	110.00%
Q4 2023	13	1	1300.00%
Q3 2023	2	-	-
Q2 2023	15	5	300.00%
Q1 2023	17	2	850.00%
Q4 2022	9	2	450.00%
Q3 2022	16	8	200.00%
Q2 2022	13	2	650.00%
Q1 2022	16	3	533.33%
Q4 2021	16	8	200.00%
Q3 2021	34	7	485.71%
Q2 2021	10	8	125.00%
Q1 2021	-	6	-
Q4 2020	5	20	25.00%
Q2 2018	-	2	-
Q1 2005	-	2	-
Q3 2004	-	4	-
Q2 2004	1	1	100.00%

1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Processa Pharmaceuticals's insiders, as of Q3 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	-	-	-
Q1 2024	6	-	-
Q4 2023	-	-	-
Q3 2023	-	-	-
Q2 2023	5	-	-
Q1 2023	-	-	-
Q4 2022	-	-	-
Q3 2022	-	-	-
Q2 2022	3	-	-
Q1 2022	-	1	-
Q4 2021	3	2	150.00%
Q3 2021	1	-	-
Q2 2021	4	8	50.00%
Q1 2021	-	6	-
Q4 2020	5	-	-
Q2 2018	-	-	-
Q1 2005	-	-	-
Q3 2004	-	-	-
Q2 2004	-	-	-

As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Processa Pharmaceuticals's stocks.

Processa Pharmaceuticals Peer Ownership

Ticker	Company
PMVP	PMV Pharmaceuticals, Inc.
FRTX	Fresh Tracks Therapeutics, Inc.
IKT	Inhibikase Therapeutics, Inc.
SABS	SAB Biotherapeutics, Inc.
ACXP	Acurx Pharmaceuticals, Inc.
INBX	Inhibrx, Inc.
FENC	Fennec Pharmaceuticals Inc.
SCPS	Scopus BioPharma Inc.
AKTX	Akari Therapeutics, Plc
ANTX	AN2 Therapeutics, Inc.
THRD	Third Harmonic Bio, Inc.
ANEB	Anebulo Pharmaceuticals, Inc.
CELC	Celcuity Inc.
MACK	Merrimack Pharmaceuticals, Inc.
ELVN	Enliven Therapeutics, Inc.
ELYM	Eliem Therapeutics, Inc.

PCSA Ownership FAQ

Who Owns Processa Pharmaceuticals?

Processa Pharmaceuticals is owned by institutional shareholders (4.19%), insiders (10.68%), and public (85.13%). The largest institutional shareholder of Processa Pharmaceuticals is WELLS FARGO & COMPANY/MN (0% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).

Who are the major institutional shareholders of Processa Pharmaceuticals?

Processa Pharmaceuticals's major institutional shareholders are WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, STATE STREET CORP, VANGUARD GROUP INC, and ROYAL BANK OF CANADA. The top five shareholders own together 0% of the company's share outstanding.

How many Processa Pharmaceuticals shareholders are there?

As of Dec 2023, there are 18 institutional shareholders of Processa Pharmaceuticals.

What percentage of Processa Pharmaceuticals is owned by WELLS FARGO & COMPANY/MN?

WELLS FARGO & COMPANY/MN owns 0 shares of Processa Pharmaceuticals, representing 0% of the company's total shares outstanding, valued at $0 (as of Mar 2024).

What percentage of Processa Pharmaceuticals is owned by NORTHERN TRUST CORP?

As of Mar 2024, NORTHERN TRUST CORP holds 0 shares of Processa Pharmaceuticals (PCSA), compromising 0% of the company, valued at $0.

What percentage of Processa Pharmaceuticals is owned by STATE STREET CORP?

STATE STREET CORP is the third largest holder of Processa Pharmaceuticals. The company owns 0 of the company's shares outstanding (worth $0).